# Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

> **NCT01181531** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 312 (actual)

## Conditions studied

- Hyperparathyroidism, Secondary

## Interventions

- **DRUG:** Traditional Vitamin D Therapy
- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT01181531
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-01
- **Primary completion:** 2012-07-17
- **Final completion:** 2012-08-14
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2018-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181531, "Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01181531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*